A general reminder that Wegovy, Zepbound and Ozempic users still need habits beyond the prescription, offered as broad wellness advice.
Recap by typeshit. Post by Facebook on Facebook.
Beauty companies are reportedly exploring products aimed at facial volume loss in people who have lost weight on GLP-1 drugs.
A short Fox16 social clip points to GLP-1 users shifting how they drink when they go out, with the full story linked in the station's bio.
A Facebook share points to shifting drinking habits in pubs and bars as more people take GLP-1 medications, with the full story linked.
Food Dive reports the Atkins brand is shifting its pitch toward lapsed GLP-1 users, a growing group food companies are now chasing.
Drugs.com
A UC San Diego trial of 166 teens found 22% held their loss a year later with mood training, versus 4% with standard counseling. No drugs involved.
Lynette Ntuli posts about a risk she says doctors flag for type 2 diabetics taking Ozempic. The text is cut off, so see her full post for details.
Loading…